Crispr Stem & Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Crispr Stem & Therapeutics General Information

Description

Developer of a cardio-protective stem cell protocol designed to be used in the treatment of heart failure. The company specializes in genetic modification, stem cell therapy development, and implantation, providing patients with a shorter recovery time post-cardiology treatment.

Contact Information

Website
www.crisprstemtherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • P.O.B. 8095
  • Petah Tikva 4918002
  • Israel
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • P.O.B. 8095
  • Petah Tikva 4918002
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Crispr Stem & Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-Apr-2024 Completed Generating Revenue
3. Early Stage VC 08-Apr-2022 Completed Generating Revenue
2. Accelerator/Incubator 01-Dec-2019 Completed Startup
1. Early Stage VC Completed Startup
To view Crispr Stem & Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Crispr Stem & Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
InnovX (Bucharest) Accelerator/Incubator
Carlson Investments Venture Capital Minority
MedTech Raanana Accelerator/Incubator
Seedbiz Corporation Minority
To view Crispr Stem & Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Crispr Stem & Therapeutics FAQs

  • When was Crispr Stem & Therapeutics founded?

    Crispr Stem & Therapeutics was founded in 2018.

  • Where is Crispr Stem & Therapeutics headquartered?

    Crispr Stem & Therapeutics is headquartered in Petah Tikva, Israel.

  • What industry is Crispr Stem & Therapeutics in?

    Crispr Stem & Therapeutics’s primary industry is Biotechnology.

  • Is Crispr Stem & Therapeutics a private or public company?

    Crispr Stem & Therapeutics is a Private company.

  • What is Crispr Stem & Therapeutics’s current revenue?

    The current revenue for Crispr Stem & Therapeutics is .

  • Who are Crispr Stem & Therapeutics’s investors?

    InnovX (Bucharest), Carlson Investments, MedTech Raanana, and Seedbiz have invested in Crispr Stem & Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process